发明名称 |
Proliferation signature and prognosis for gastrointestinal cancer |
摘要 |
Provided is a method of predicting the likelihood of long-term survival of a gastrointestinal cancer patient without the recurrence of gastrointestinal cancer, comprising determining the expression level of one or more prognostic RNA transcripts or their expression products in a gastrointestinal sample obtained from the patient, normalized against the expression level of all RNA transcripts or their products in the gastrointestinal cancer tissue sample, or of a reference set of RNA transcripts or their expression products; wherein the prognostic RNA transcript or expression product comprises the transcript of replication factor (activator 1) 4 (RFC4); and establishing likelihood of long-term survival without gastrointestinal cancer recurrence wherein increased expression of the one or more prognostic RNA transcripts or their expression products indicates an increased likelihood of long-term survival without gastrointestinal cancer recurrence.
|
申请公布号 |
NZ562237(A) |
申请公布日期 |
2011.02.25 |
申请号 |
NZ20070562237 |
申请日期 |
2007.10.05 |
申请人 |
PACIFIC EDGE BIOTECHNOLOGY LTD |
发明人 |
ANJOMSHOAA, AHMAD;REEVE, ANTHONY EDMUND;LIN, YU-HSIN;BLACK, MICHAEL A |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|